Citations (213)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (28)
Sohee Jeong, Kyung Sik Yoon, Jin-Moo Lee, Eun Sung Jo, Dojung Kim & Sun Ok Choi. (2023) Neurotoxic and cardiotoxic effects of N-methyl-1-(naphthalen-2-yl)propan-2-amine (methamnetamine) and 1-phenyl-2-pyrrolidinylpentane (prolintane). Drug and Chemical Toxicology 46:3, pages 430-440.
Read now
Read now
Benjamin Crulli, Alison M. Dines, Georgina Blanco, Isabelle Giraudon, Florian Eyer, Matthias E. Liechti, Òscar Miró, Knut E. Hovda, Fridtjof Heyerdahl, Christopher Yates, Odd Martin Vallersnes, David M. Wood, Paul I. Dargan, Lukasz Anand, Kurt Anseeuw, Robertas Badaras, Jeffrey Bonnici, Miran Brvar, Blazena Caganova, Feriyde Calýskan, Alessandro Ceschi, Karam Chamoun, Laurence Daveloose, Miguel Galicia, Stefanie Geith, Ketevan Gorozia, Damjan Grenc, Femke Gresnigt, Laura Hondebrink, Gesche Jürgens, Jutta Konstari, Soso Kutubidze, Gabija Laubner, Evangelia Liakoni, Viesturs Liguts, Cathelijne Lyphout, Thomas MacMahon, Bruno Mégarbane, Adrian Moughty, Gabriela Viorela Nitescu, Roberta Noseda, Niall O'Connor, Raido Paasma, Juan Ortega Perez, Marius Perminas, Per Sverre Persett, Kristiina Põld, Jordi Puiguriguer, Julia Radenkova-Saeva, Jan Rulisek, Yasmin Schmid, Irene Scholz, Roberts Stašinskis, Jonas Surkus, Wesley van den Busken, Irma van den Hengel-Koot, Federico Vigorita, Wojciech Waldmanm, William Stephen Waring & Sergej Zacharov. (2022) Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014–2019. Clinical Toxicology 60:12, pages 1318-1327.
Read now
Read now
Kristina Domanski, Steven W Fleming, Hayden Maag, Emily Bouso Raley, Joshua DeBord, Brooks Wright & Roya Mahana. (2022) A Psychonaut’s Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis. Journal of Psychoactive Drugs 54:4, pages 319-323.
Read now
Read now
Te-I Weng, Hsien-Yi Chen, Lengsu W. Chin, Hsin-Hui Chou, Meng-Huan Wu, Guan-yuan Chen, Ju-Yu Chen, Chia-Pang Shih, Chih-Chuan Lin & Cheng-Chung Fang. (2022) Comparison of clinical characteristics between meth/amphetamine and synthetic cathinone users presented to the emergency department. Clinical Toxicology 60:8, pages 926-932.
Read now
Read now
Qi-Di Hu, Ling-Li Xu, Yan Gong, Guo-Hai Wu, Yu-Wen Wang, Shan-Jun Wu, Zhe Zhang, Wei Mao, Yu-Sheng Zhou, Qin-Bo Li & Jian-Shu Yuan. (2018) Lysergic acid diethylamide causes photoreceptor cell damage through inducing inflammatory response and oxidative stress. Cutaneous and Ocular Toxicology 37:3, pages 233-239.
Read now
Read now
Amary Mey, David Plummer, Shailendra Anoopkumar-Dukie & Amber Domberelli. (2018) What’s the attraction? Social connectedness as a driver of recreational drug use. Journal of Substance Use 23:3, pages 327-334.
Read now
Read now
Amary Mey, David Plummer, Shailendra Anoopkumar-Dukie & Amber Domberelli. (2018) What’s the attraction? The role of performance enhancement as a driver of recreational drug use. Journal of Substance Use 23:3, pages 294-299.
Read now
Read now
Álvaro José Palma-Conesa, Mireia Ventura, Liliana Galindo, Francina Fonseca, Marc Grifell, Pol Quintana, Iván Fornís, Cristina Gil, Magí Farré & Marta Torrens. (2017) Something New about Something Old: A 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis. Journal of Psychoactive Drugs 49:4, pages 297-305.
Read now
Read now
NW Brown. (2017) Toxicology in clinical laboratories: challenging times. British Journal of Biomedical Science 74:3, pages 110-120.
Read now
Read now
Monika Židková, Igor Linhart, Marie Balíková, Michal Himl, Lubomír Váňa, Michal Vetýška, Tomáš Páleníček, Eva Lhotková & Martin Dušek. (2017) Study on the metabolism of 5,6-methylenedioxy-2-aminoindane (MDAI) in rats: identification of urinary metabolites. Xenobiotica 47:6, pages 505-514.
Read now
Read now
K. Domanski, K.C. Kleinschmidt, J. M. Schulte, S. Fleming, C. Frazee, A. Menendez & K. Tavakoli. (2017) Two cases of intoxication with new synthetic opioid, U-47700. Clinical Toxicology 55:1, pages 46-50.
Read now
Read now
Elisabetta Bertol, Fabio Vaiano, Francesco Mari, Maria Grazia Di Milia, Silvia Bua, Claudiu T. Supuran & Fabrizio Carta. (2017) Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium. Journal of Enzyme Inhibition and Medicinal Chemistry 32:1, pages 841-849.
Read now
Read now
Fabrizio Schifano, G. Duccio Papanti, Laura Orsolini & John M. Corkery. (2016) Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. Expert Review of Clinical Pharmacology 9:7, pages 943-954.
Read now
Read now
Kayla N. Ellefsen, Marta Concheiro & Marilyn A. Huestis. (2016) Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases. Drug Metabolism Reviews 48:2, pages 237-265.
Read now
Read now
Anders Helander, Olof Beck & Matilda Bäckberg. (2015) Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine. Clinical Toxicology 53:5, pages 446-453.
Read now
Read now
Panagiota Nikolaou, Ioannis Papoutsis, Maria Stefanidou, Chara Spiliopoulou & Sotiris Athanaselis. (2015) 2C-I-NBOMe, an “N-bomb” that kills with “Smiles”. Toxicological and legislative aspects. Drug and Chemical Toxicology 38:1, pages 113-119.
Read now
Read now
Marie Claire Van Hout & Evelyn Hearne. (2015) “Word of Mouse”: Indigenous Harm Reduction and Online Consumerism of the Synthetic Compound Methoxphenidine. Journal of Psychoactive Drugs 47:1, pages 30-41.
Read now
Read now
Ashraf Kamour, David James, David J. Lupton, Gillian Cooper, Micheal Eddleston, Allister Vale, John P. Thompson, Ruben Thanacoody, Simon L. Hill & Simon H. L. Thomas. (2014) Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the ‘benzofuran’ compounds. A report from the United Kingdom National Poisons Information Service. Clinical Toxicology 52:10, pages 1025-1031.
Read now
Read now
Marie Claire Van Hout. (2014) An Internet Study of User’s Experiences of the Synthetic Cathinone 4-Methylethcathinone (4-MEC). Journal of Psychoactive Drugs 46:4, pages 273-286.
Read now
Read now
M. Bäckberg, O. Beck, P. Hultén, J. Rosengren-Holmberg & A. Helander. (2014) Intoxications of the new psychoactive substance 5-(2-aminopropyl)indole (5-IT): A case series from the Swedish STRIDA project. Clinical Toxicology 52:6, pages 618-624.
Read now
Read now
M. H. Y. Tang, C. K. Ching, M. S. H. Tsui, F. K. C. Chu & T. W. L. Mak. (2014) Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe. Clinical Toxicology 52:5, pages 561-565.
Read now
Read now
. (2014) XXXIV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 27–30 May 2014, Brussels, Belgium. Clinical Toxicology 52:4, pages 295-443.
Read now
Read now
A. Kamour, D. James, R. Spears, G. Cooper, D. J. Lupton, M. Eddleston, J. P. Thompson, A. J. Vale, H. K. R. Thanacoody, S. L. Hill & S. H. L. Thomas. (2014) Patterns of presentation and clinical toxicity after reported use of alpha methyltryptamine in the United Kingdom. A report from the UK National Poisons Information Service. Clinical Toxicology 52:3, pages 192-197.
Read now
Read now
Anders Helander, Olof Beck, Robert Hägerkvist & Peter Hultén. (2013) Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project. Scandinavian Journal of Clinical and Laboratory Investigation 73:5, pages 400-406.
Read now
Read now
. (2013) XXXIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 28–31 May 2013, Copenhagen, Denmark. Clinical Toxicology 51:4, pages 252-378.
Read now
Read now
M. Petrie, K. L. Lynch, S. Ekins, J. S. Chang, R. J. Goetz, A. H. B. Wu & M. D. Krasowski. (2013) Cross-reactivity studies and predictive modeling of “Bath Salts” and other amphetamine-type stimulants with amphetamine screening immunoassays. Clinical Toxicology 51:2, pages 83-91.
Read now
Read now
A. Ceschi, G. Giardelli, D. M. Müller, S. Elavumkudy, A. F. Manini, C. Rauber-Lüthy & K. E. Hofer. (2013) Acute neurotoxicity associated with recreational use of methylmethaqualone confirmed by liquid chromatography tandem mass spectrometry. Clinical Toxicology 51:1, pages 54-57.
Read now
Read now
David M. Wood & Paul I. Dargan. (2012) Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP). Clinical Toxicology 50:8, pages 727-732.
Read now
Read now
Articles from other publishers (185)
Fei Wang, Daniel Pasin, Michael A. Skinnider, Jaanus Liigand, Jan-Niklas Kleis, David Brown, Eponine Oler, Tanvir Sajed, Vasuk Gautam, Stephen Harrison, Russell Greiner, Leonard J. Foster, Petur Weihe Dalsgaard & David S. Wishart. (2023) Deep Learning-Enabled MS/MS Spectrum Prediction Facilitates Automated Identification Of Novel Psychoactive Substances. Analytical Chemistry.
Crossref
Crossref
Hyun-A. Oh, Jae Hong Yoo, Ye-Ji Kim, Kyung-Seok Han & Dong Ho Woo. (2023) 4-EA-NBOMe, an amphetamine derivative, alters glutamatergic synaptic transmission through 5-HT1A receptors on cortical neurons from Sprague Dawley rat and pyramidal neurons from C57BL/6 mouse. NeuroToxicology 95, pages 144-154.
Crossref
Crossref
Fateme Zohairi, Himanshu Khandelia & Ali Asghar Hakami Zanjani. (2023) Interaction of psychedelic tryptamine derivatives with a lipid bilayer. Chemistry and Physics of Lipids 251, pages 105279.
Crossref
Crossref
Carlo Alessandro Locatelli, Davide Lonati, Azzurra Schicchi & Valeria Margherita Petrolini. 2023. Autonomic Disorders in Clinical Practice. Autonomic Disorders in Clinical Practice
397
432
.
Jakub Czarny, Jadwiga Musiał, Jolanta Powierska-Czarny, Natalia Galant, Michał Raczkowski, Bogusław Buszewski & Renata Gadzała-Kopciuch. (2022) Validation of a simple and quick method for determination of psychoactive substances, drugs and their metabolites from human blood by LC-MS/MS. Microchemical Journal 182, pages 107922.
Crossref
Crossref
Wenya Zhai, Le Li, Junbo Zhao, Ping Xiang, Mengxi Liu, Yan Shi & Yonghui Dang. (2022)
Tentative identification of in vitro metabolites of
O
‐acetylpsilocin (psilacetin, 4‐AcO‐DMT) by UHPLC‐Q‐Orbitrap MS
. Drug Testing and Analysis 14:7, pages 1300-1309.
Crossref
Crossref
Ana Y. Simão, Mónica Antunes, Emanuel Cabral, Patrik Oliveira, Luana M. Rosendo, Ana Teresa Brinca, Estefânia Alves, Hernâni Marques, Tiago Rosado, Luís A. Passarinha, Maristela Andraus, Mário Barroso & Eugenia Gallardo. (2022) An Update on the Implications of New Psychoactive Substances in Public Health. International Journal of Environmental Research and Public Health 19:8, pages 4869.
Crossref
Crossref
Deborah Rudin, John D. McCorvy, Grant C. Glatfelter, Dino Luethi, Dániel Szöllősi, Tea Ljubišić, Pierce V. Kavanagh, Geraldine Dowling, Marion Holy, Kathrin Jaentsch, Donna Walther, Simon D. Brandt, Thomas Stockner, Michael H. Baumann, Adam L. Halberstadt & Harald H. Sitte. (2021) (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice. Neuropsychopharmacology 47:4, pages 914-923.
Crossref
Crossref
Shaun L. Greene. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
495
532
.
Adam J. Potts, Simon H.L. Thomas & Simon L. Hill. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
279
300
.
Jeff Lapoint & Katherine L. Welker. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
247
278
.
Dima Abdulrahim & Owen Bowden-Jones. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
203
222
.
Arie P. Francis & Silas W. Smith. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
57
84
.
Andreas BüttnerAndreas Büttner. 2022. Neuropathologie des Drogenmissbrauchs. Neuropathologie des Drogenmissbrauchs
23
90
.
Neelambika Revadigar, Ching Tary Yu & Isabelle Silverstone-Simard. 2022. Substance and Non-Substance Related Addictions. Substance and Non-Substance Related Addictions
185
194
.
Sherilyn K.D. Houle, Derek Evans, Caitlin A. Carter & Patricia Schlagenhauf. (2021) Ayahuasca and the traveller: A scoping review of risks and possible benefits. Travel Medicine and Infectious Disease 44, pages 102206.
Crossref
Crossref
Fevzi Topal, Kadir Aksu, Ilhami Gulcin, Ferhan Tümer & Süleyman Goksu. (2021) Inhibition Profiles of Some Symmetric Sulfamides Derived from Phenethylamines on Human Carbonic Anhydrase I, and II Isoenzymes. Chemistry & Biodiversity 18:10.
Crossref
Crossref
Paola Vitale, Luciana Cicco, Filippo Maria Perna & Vito Capriati. (2021) Introducing deep eutectic solvents in enolate chemistry: synthesis of 1-arylpropan-2-ones under aerobic conditions. Reaction Chemistry & Engineering 6:10, pages 1796-1800.
Crossref
Crossref
Kristin Waters. (2021) Pharmacologic Similarities and Differences Among Hallucinogens. The Journal of Clinical Pharmacology 61:S2.
Crossref
Crossref
Lara Prisco, Aarti Sarwal, Mario Ganau & Francesca Rubulotta. (2021) Toxicology of Psychoactive Substances. Critical Care Clinics 37:3, pages 517-541.
Crossref
Crossref
F. Lapostolle & S. Beaune. (2021) Ecstasy : la deuxième vague…. Annales françaises de médecine d’urgence 11:2, pages 100-111.
Crossref
Crossref
Vera Lukić, Ružica Micić, Biljana Arsić, Bojan Nedović & Živana Radosavljević. (2021) Overview of the major classes of new psychoactive substances, psychoactive effects, analytical determination and conformational analysis of selected illegal drugs. Open Chemistry 19:1, pages 60-106.
Crossref
Crossref
Andreas BüttnerAndreas Büttner. 2021. Neuropathology of Drug Abuse. Neuropathology of Drug Abuse
23
87
.
Magi Farré, Esther Papaseit, Francina Fonseca & Marta Torrens. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment
259
279
.
Veronica Cocchi, Sofia Gasperini, Patrizia Hrelia, Micaela Tirri, Matteo Marti & Monia Lenzi. (2020) Novel Psychoactive Phenethylamines: Impact on Genetic Material. International Journal of Molecular Sciences 21:24, pages 9616.
Crossref
Crossref
Kwaku Kyei-Baffour & Craig W. Lindsley. (2020)
DARK
Classics in Chemical Neuroscience: U-47700
. ACS Chemical Neuroscience 11:23, pages 3928-3936.
Crossref
Crossref
Te-I Weng, Lian-Yu Chen, Ju-Yu Chen, Pai-Shan Chen, Hsaio-Lin Hwa & Cheng-Chung Fang. (2020) Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department. Journal of the Formosan Medical Association 119:12, pages 1827-1834.
Crossref
Crossref
Micaela Tirri, Luisa Ponzoni, Sabrine Bilel, Raffaella Arfè, Daniela Braida, Mariaelvina Sala & Matteo Marti. (2020) Acute DOB and PMA Administration Impairs Motor and Sensorimotor Responses in Mice and Causes Hallucinogenic Effects in Adult Zebrafish. Brain Sciences 10:9, pages 586.
Crossref
Crossref
Bruno Mégarbane, Camille Gamblin, Olivier Roussel, Elodie Bouaziz-Amar, Lucie Chevillard, Jacques Callebert, Huixiong Chen, Gilles Morineau, Jean-Louis Laplanche, Mélanie Etheve-Quelquejeu, Matthias E. Liechti & Nadia Benturquia. (2020) The neurobehavioral effects of the designer drug naphyrone – an experimental investigation with pharmacokinetics and concentration/effect relationship in mice. Psychopharmacology 237:7, pages 1943-1957.
Crossref
Crossref
Raffaella Rinaldi, Giuseppe Bersani, Enrico Marinelli & Simona Zaami. (2020) The rise of new psychoactive substances and psychiatric implications: A wide‐ranging, multifaceted challenge that needs far‐reaching common legislative strategies. Human Psychopharmacology: Clinical and Experimental 35:3.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Katharina Elisabeth Grafinger, Matthias E. Liechti & Evangelia Liakoni. (2019) Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication. British Journal of Clinical Pharmacology 86:3, pages 429-436.
Crossref
Crossref
I. Al-Banaa, L. Hawkins, S.L. Hill, D.J. Lupton, G. Jackson, E.A. Sandilands, S.M. Bradberry, J.P. Thompson, S. Rushton & S.H.L. Thomas. (2020) Effect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service. A time series analysis. International Journal of Drug Policy 77, pages 102672.
Crossref
Crossref
Arvie Abiero, Chrislean Jun Botanas, Raly James Custodio, Leandro Val Sayson, Mikyung Kim, Hyun Jun Lee, Hee Jin Kim, Kun Won Lee, Youngdo Jeong, Joung-Wook Seo, In Soo Ryu, Yong Sup Lee & Jae Hoon Cheong. (2019) 4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels. Psychopharmacology 237:3, pages 757-772.
Crossref
Crossref
Juan José Fuentes, Francina Fonseca, Matilde Elices, Magí Farré & Marta Torrens. (2020) Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials. Frontiers in Psychiatry 10.
Crossref
Crossref
Giulia Costa, MariaAntonietta De Luca, Gessica Piras, Jacopo Marongiu, Liana Fattore & Nicola Simola. (2020) Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies. Neural Regeneration Research 15:5, pages 802.
Crossref
Crossref
Arvie Abiero, In Soo Ryu, Chrislean Jun Botanas, Raly James Perez Custodio, Leandro Val Sayson, Mikyung Kim, Hyun Jun Lee, Hee Jin Kim, Joung-Wook Seo, Min Chang Cho, Kun Won Lee, Sung Yeun Yoo, Choon-Gon Jang, Yong Sup Lee & Jae Hoon Cheong. (2020) Four Novel Synthetic Tryptamine Analogs Induce Head-Twitch Responses and Increase 5-HTR2a in the Prefrontal Cortex in Mice. Biomolecules & Therapeutics 28:1, pages 83-91.
Crossref
Crossref
Johan Duflou. (2019) Psychostimulant use disorder and the heart. Addiction 115:1, pages 175-183.
Crossref
Crossref
Mark Petersen, Uttam Garg & Hemamalini Ketha. 2020. Toxicology Cases for the Clinical and Forensic Laboratory. Toxicology Cases for the Clinical and Forensic Laboratory
295
303
.
Carlo Alessandro Locatelli, Davide Lonati & Valeria Margherita Petrolini. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics
1
27
.
Carlo Alessandro Locatelli, Davide Lonati & Valeria Margherita Petrolini. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics
843
868
.
Yongho Shin, Tae Yeon Kong, Jae Cheol Cheong, Jin Young Kim, Jae Il Lee & Hye Suk Lee. (2019) Simultaneous determination of 75 abuse drugs including amphetamines, benzodiazepines, cocaine, opioids, piperazines, zolpidem and metabolites in human hair samples using liquid chromatography–tandem mass spectrometry. Biomedical Chromatography 33:9.
Crossref
Crossref
Margalho Cláudia, Almeida Pedro, Rosado Tiago, Corte Real Francisco & Gallardo Eugenia. (2019) Determination of New Psychoactive Substances in Whole Blood Using Microwave Fast Derivatization and Gas Chromatography/Mass Spectrometry. Journal of Analytical Toxicology.
Crossref
Crossref
Yoshimi Peck, Alan R. Clough, Peter N. Culshaw & Michael J. Liddell. (2019) Multi-drug cocktails: Impurities in commonly used illicit drugs seized by police in Queensland, Australia. Drug and Alcohol Dependence 201, pages 49-57.
Crossref
Crossref
James W. Firman, Samuel J. Belfield, George Chen, Megan Jackson, Fai Hou Lam, Callum Richmond, James Smith, Fabian P. Steinmetz & Mark T. D. Cronin. (2019) Chemoinformatic Consideration of Novel Psychoactive Substances: Compilation and Preliminary Analysis of a Categorised Dataset. Molecular Informatics 38:8-9, pages 1800142.
Crossref
Crossref
Monika Herian, Adam Wojtas, Katarzyna Kamińska, Paweł Świt, Anna Wach & Krystyna Gołembiowska. (2019) Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats. Neurotoxicity Research 36:1, pages 91-100.
Crossref
Crossref
Katharina Elisabeth Grafinger, Andreas Wilke, Stefan König & Wolfgang Weinmann. (2018)
Investigating the ability of the microbial model
Cunninghamella elegans
for the metabolism of synthetic tryptamines
. Drug Testing and Analysis 11:5, pages 721-729.
Crossref
Crossref
Patil Armenian, Zachary Effron, Neev Garbi, Rachel Dirks, Neal L. Benowitz & Roy R. Gerona. (2019) Stimulant drugs are associated with violent and penetrating trauma. The American Journal of Emergency Medicine 37:4, pages 645-650.
Crossref
Crossref
H Jiang & H Xu. (2018) RETRACTED: Long-term systemic treatment with lysergic acid diethylamide causes retinal damage in CD1 mice. Human & Experimental Toxicology 38:3, pages 347-355.
Crossref
Crossref
M. Rosaria Varì, Simona Pichini, Raffaele Giorgetti & Francesco P. Busardò. (2018) New psychoactive substances—Synthetic stimulants. WIREs Forensic Science 1:2.
Crossref
Crossref
Arvie Abiero, Chrislean Jun Botanas, Leandro Val Sayson, Raly James Custodio, June Bryan de la Peña, Mikyung Kim, Hyun Jun Lee, Joung-Wook Seo, In Soo Ryu, Cho Min Chang, Ji Seul Yang, Yong Sup Lee, Choon-Gon Jang, Hee Jin Kim & Jae Hoon Cheong. (2019) 5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex. Behavioural Brain Research 359, pages 828-835.
Crossref
Crossref
William J Scotton, Lisa J Hill, Adrian C Williams & Nicholas M Barnes. (2019) Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International Journal of Tryptophan Research 12, pages 117864691987392.
Crossref
Crossref
Minjeong Kim, Chae Ha Yang, Yong Sup Lee, Choon-Gon Jang, Seikwan Oh & Sooyeun Lee. (2018) Effects of aromatic ring-substituted phenethylamines on the release of dopamine and serotonin. Forensic Toxicology 37:1, pages 104-112.
Crossref
Crossref
S. Iwersen-Bergmann, S. Lehmann, A. Heinemann, C. Schröder, A. Müller, H. Jungen, H. Andresen-Streichert, K. Pueschel, C. Vidal & K. Mercer-Chalmers-Bender. (2018) Mass poisoning with NPS: 2C-E and Bromo-DragonFly. International Journal of Legal Medicine 133:1, pages 123-129.
Crossref
Crossref
Janice Pettie, Allan Burt, Duleeka W. Knipe, Hazel Torrance, Margaret Dow, Karen Osinski, Robert Greig, Diletta Sabatini, Kate Easterford, James Dear & Michael Eddleston. (2018) New drug controls and reduced hospital presentations due to novel psychoactive substances in Edinburgh. British Journal of Clinical Pharmacology 84:10, pages 2303-2310.
Crossref
Crossref
Carolina Noble, Niels Bjerre Holm, Marie Mardal & Kristian Linnet. (2018) Bromo-dragonfly, a psychoactive benzodifuran, is resistant to hepatic metabolism and potently inhibits monoamine oxidase A. Toxicology Letters 295, pages 397-407.
Crossref
Crossref
Pia Simona Bruni, Katharina Elisabeth Grafinger, Susanne Nussbaumer, Stefan König, Stefan Schürch & Wolfgang Weinmann. (2018) Study of the in vitro and in vivo metabolism of 4-HO-MET. Forensic Science International 290, pages 103-110.
Crossref
Crossref
Ryan Graddy, Megan E. Buresh & Darius A. Rastegar. (2018) New and Emerging Illicit Psychoactive Substances. Medical Clinics of North America 102:4, pages 697-714.
Crossref
Crossref
Sajjadur Rehman, OmSaiRamesh Vallamkonda & Nitin B. Raut. (2018) Acute recreational drug toxicity: An update. Indian Journal of Medical Specialities 9:3, pages 123-128.
Crossref
Crossref
Brenda M. Gannon, Adrian Williamson, Kenner C. Rice & William E. Fantegrossi. (2018) Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice. Neuropharmacology 134, pages 13-21.
Crossref
Crossref
Evangelia Liakoni, Fabienne Gartwyl, Meret Ricklin, Aristomenis K. Exadaktylos & Stephan Krähenbühl. (2018) Psychoactive substances and violent offences: A retrospective analysis of presentations to an urban emergency department in Switzerland. PLOS ONE 13:3, pages e0195234.
Crossref
Crossref
Katharina Elisabeth Grafinger, Marianne Hädener, Stefan König & Wolfgang Weinmann. (2018)
Study of the
in vitro
and
in vivo
metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples
. Drug Testing and Analysis 10:3, pages 562-574.
Crossref
Crossref
Matthew D. Krasowski & Sean Ekins. 2018. Computational Toxicology. Computational Toxicology
175
209
.
Evangelia Liakoni, Christopher Yates, Alison M. Dines, Paul I. Dargan, Fridtjof Heyerdahl, Knut Erik Hovda, David M. Wood, Florian Eyer & Matthias E. Liechti. (2018) Acute recreational drug toxicity. Medicine 97:5, pages e9784.
Crossref
Crossref
Basile Chrétien, Joanna Bourgine, Léa Hamel Sénécal, Marie Bretaudeau-Deguigne, David Boels, Véronique Lelong-Boulouard & Reynald Le Boisselier. (2018) Severe Serotonin Syndrome in an Autistic New Psychoactive Substance User After Consumption of Pills Containing Methoxphenidine and α-Methyltryptamine. Journal of Clinical Psychopharmacology 38:1, pages 94-96.
Crossref
Crossref
Khalid A. Alsenedi & Calum Morrison. (2018) Determination and long-term stability of twenty-nine cathinones and amphetamine-type stimulants (ATS) in urine using gas chromatography–mass spectrometry. Journal of Chromatography B 1076, pages 91-102.
Crossref
Crossref
Klára Šíchová, Nikola Pinterová, Monika Židková, Rachel R. Horsley, Eva Lhotková, Kristýna Štefková, Čestmír Vejmola, Libor Uttl, Marie Balíková, Martin Kuchař & Tomáš Páleníček. (2018) Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats. Frontiers in Psychiatry 8.
Crossref
Crossref
Andrew King, Mirjana Dimovska & Luke Bisoski. (2018) Sympathomimetic Toxidromes and Other Pharmacological Causes of Acute Hypertension. Current Hypertension Reports 20:1.
Crossref
Crossref
Thomas GeschwindeThomas Geschwinde. 2018. Rauschdrogen. Rauschdrogen
1
392
.
Simon L. Hill & Paul I. Dargan. 2018. New Psychoactive Substances. New Psychoactive Substances
475
494
.
Linda D. Simmler & Matthias E. Liechti. 2018. New Psychoactive Substances. New Psychoactive Substances
143
164
.
Evangelia Liakoni, Sabine Müller, Adrian Stoller, Meret Ricklin, Matthias E. Liechti & Aristomenis K. Exadaktylos. (2017) Presentations to an urban emergency department in Bern, Switzerland associated with acute recreational drug toxicity. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 25:1.
Crossref
Crossref
Daniel Pasin, Adam Cawley, Sergei Bidny & Shanlin Fu. (2017) Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review. Analytical and Bioanalytical Chemistry 409:25, pages 5821-5836.
Crossref
Crossref
Michael J. Paul & Mark Dredze. (2017) Social Monitoring for Public Health. Synthesis Lectures on Information Concepts, Retrieval, and Services 9:5, pages 1-183.
Crossref
Crossref
Luisa Ponzoni, Daniela Braida, Gianpietro Bondiolotti & Mariaelvina Sala. (2017) The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish. Frontiers in Psychiatry 8.
Crossref
Crossref
Robson Savoldi, Daniel Polari, Jaquelinne Pinheiro-da-Silva, Priscila F. Silva, Bruno Lobao-Soares, Mauricio Yonamine, Fulvio A. M. Freire & Ana C. Luchiari. (2017) Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish. Frontiers in Behavioral Neuroscience 11.
Crossref
Crossref
Stephen J. deRoux & William A. Dunn. (2017) “Bath Salts” the New York City Medical Examiner Experience: A 3-Year Retrospective Review. Journal of Forensic Sciences 62:3, pages 695-699.
Crossref
Crossref
Anders Helander. 2017. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation
83
99
.
David J. Lowe, Hazel J. Torrance, Alastair J. Ireland, Felix Bloeck & Richard Stevenson. (2017) SODAS. European Journal of Emergency Medicine 24:2, pages 126-129.
Crossref
Crossref
Chadi Abbara, S?verine Ferec, Ga?l Leroux, Marie Bretaudeau-Deguigne, B?n?dicte Lelievre, David Boels & Alain Turcant. (2017) 2,5-dimethoxy-4-chloroamphetamine, a LSD-like designer drug: Clinical and analytical documentation of non-fatal exposure in five patients. Toxicologie Analytique et Clinique 29:1, pages 82-89.
Crossref
Crossref
Tae Yeon Kong, Ju Hyun Kim, Jin Young Kim, Moon Kyo In, Kyung Ho Choi, Hee Seung Kim & Hye Suk Lee. (2016) Rapid analysis of drugs of abuse and their metabolites in human urine using dilute and shoot liquid chromatography?tandem mass spectrometry. Archives of Pharmacal Research 40:2, pages 180-196.
Crossref
Crossref
Adrian Stoller, Patrick C. Dolder, Michael Bodmer, Felix Hammann, Katharina M. Rentsch, Aristomenis K. Exadaktylos, Matthias E. Liechti & Evangelia Liakoni. (2017) Mistaking 2C-P for 2C-B: What a Difference a Letter Makes. Journal of Analytical Toxicology 41:1, pages 77-79.
Crossref
Crossref
Paul R. Smith & Stephen R. Morley. 2017. Essentials of Autopsy Practice. Essentials of Autopsy Practice
59
85
.
Evangelia Liakoni, Patrick C. Dolder, Katharina M. Rentsch & Matthias E. Liechti. (2016) Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series. BMC Pharmacology and Toxicology 17:1.
Crossref
Crossref
Odd Martin Vallersnes, Alison M. Dines, David M. Wood, Christopher Yates, Fridtjof Heyerdahl, Knut Erik Hovda, Isabelle Giraudon & Paul I. Dargan. (2016) Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry 16:1.
Crossref
Crossref
Cecilia L. Moore, Heather F. Gidding, Fengyi Jin, Limin Mao, Kathy Petoumenos, Iryna B. Zablotska, I. Mary Poynten, Garrett Prestage, Matthew G. Law, Andrew E. Grulich & Janaki Amin. (2016) Patterns of Drug Use and Drug-related Hospital Admissions in HIV-Positive and -Negative Gay and Bisexual Men. AIDS and Behavior 20:10, pages 2372-2386.
Crossref
Crossref
Andreas Carlsson, Sandra Lindberg, Xiongyu Wu, Simon Dunne, Martin Josefsson, Crister Åstot & Johan Dahlén. (2016)
Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1
H
-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1
H
-indol-3-yl(adamantan-1-yl)methanone
. Drug Testing and Analysis 8:10, pages 1015-1029.
Crossref
Crossref
Michael J. Paul, Margaret S. Chisolm, Matthew W. Johnson, Ryan G. Vandrey & Mark Dredze. (2016) Assessing the Validity of Online Drug Forums as a Source for Estimating Demographic and Temporal Trends in Drug Use. Journal of Addiction Medicine 10:5, pages 324-330.
Crossref
Crossref
Erica Bakota, Crystal Arndt, Amelia A. Romoser & Stephen K. Wilson. (2016) Fatal Intoxication Involving 3-MeO-PCP: A Case Report and Validated Method. Journal of Analytical Toxicology 40:7, pages 504-510.
Crossref
Crossref
Mounir Ouzir & Mohammed Errami. (2016) Etiological theories of addiction: A comprehensive update on neurobiological, genetic and behavioural vulnerability. Pharmacology Biochemistry and Behavior 148, pages 59-68.
Crossref
Crossref
Ethan M. McBride, Amanda Kretsch, Luis K. Garibay, Katie Brigance, Benji Frey, Brandon Buss & Guido F. Verbeck. (2016) Rapid experimental and computational determination of phenethylamine drug analogue lipophilicity. Forensic Chemistry 1, pages 58-65.
Crossref
Crossref
Luisa Ponzoni, Braida Daniela & Mariaelvina Sala. (2016) Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors. Psychopharmacology 233:15-16, pages 3031-3039.
Crossref
Crossref
Sean Sassano-Higgins, Dave Baron, Grace Juarez, Neevon Esmaili & Mark Gold. (2016) A REVIEW OF KETAMINE ABUSE AND DIVERSION. Depression and Anxiety 33:8, pages 718-727.
Crossref
Crossref
Xi-Ling Jiang, Hong-Wu Shen & Ai-Ming Yu. (2016) Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms. Pharmacological Reports 68:3, pages 608-615.
Crossref
Crossref
Séverine Férec, Isabelle Leborgne, Chloé Bruneau, Joanna Bourgine, Xavier Valette, Chadi Abbara, Bénédicte Lelièvre, David Boels, Marie Bretaudeau-Deguigne & Alain Turcant. (2016) Severe serotoninergic syndrome after ingestion of α-methyltryptamine. Toxicologie Analytique et Clinique 28:1, pages 71-78.
Crossref
Crossref
Simon L. Hill & Simon H.L. Thomas. (2016) Drugs of abuse. Medicine 44:3, pages 160-169.
Crossref
Crossref
Julie A. Marusich, Kateland R. Antonazzo, Bruce E. Blough, Simon D. Brandt, Pierce V. Kavanagh, John S. Partilla & Michael H. Baumann. (2016) The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue. Neuropharmacology 101, pages 68-75.
Crossref
Crossref
Hege M. Krabseth, Silja S. Tuv, Maren Cecilie Strand, Ritva A. Karinen, Elisabeth Wiik, Merete S. Vevelstad, Andreas Austgulen Westin, Elisabeth L. Øiestad & Vigdis Vindenes. (2016) Nye psykoaktive stoffer. Tidsskrift for Den norske legeforening 136:8, pages 714-717.
Crossref
Crossref
Matthew Kirkpatrick, Casey Guillot & Carl Hart. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
463
472
.
Esther Papaseit, José Moltó, Robert Muga, Marta Torrens, Rafael de la Torre & Magí Farré. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
313
331
.
Linda D. Simmler & Matthias E. Liechti. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
49
72
.
Michael F Weaver, John A Hopper & Erik W Gunderson. (2015) Designer drugs 2015: assessment and management. Addiction Science & Clinical Practice 10:1.
Crossref
Crossref
Anna Rickli, Dino Luethi, Julian Reinisch, Danièle Buchy, Marius C. Hoener & Matthias E. Liechti. (2015) Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology 99, pages 546-553.
Crossref
Crossref
P. Díez Romero, M. Gallego Alonso-Colmenares, J. Fernández Herranz & M. Ganzo Pión. (2015) Intoxicaciones agudas por alcohol, otras drogas y fármacos psicoactivos. Medicine - Programa de Formación Médica Continuada Acreditado 11:89, pages 5314-5323.
Crossref
Crossref
Joseph J. Palamar, Silvia S. Martins, Mark K. Su & Danielle C. Ompad. (2015) Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug and Alcohol Dependence 156, pages 112-119.
Crossref
Crossref
Joseph J. Palamar. (2015) “Bath salt” use among a nationally representative sample of high school seniors in the United States. The American Journal on Addictions 24:6, pages 488-491.
Crossref
Crossref
Gaël Le Roux, Chloé Bruneau, Bénédicte Lelièvre, Marie Bretaudeau Deguigne, Alain Turcant, Patrick Harry & David Boels. (2015) Recreational phenethylamine poisonings reported to a French poison control center. Drug and Alcohol Dependence 154, pages 46-53.
Crossref
Crossref
Ana Margarida Araújo, Félix Carvalho, Maria de Lourdes Bastos, Paula Guedes de Pinho & Márcia Carvalho. (2015) The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology 89:8, pages 1151-1173.
Crossref
Crossref
Anna Rickli, Simone Kopf, Marius C Hoener & Matthias E Liechti. (2015) Pharmacological profile of novel psychoactive benzofurans. British Journal of Pharmacology 172:13, pages 3412-3425.
Crossref
Crossref
Maria Katselou, Ioannis Papoutsis, Panagiota Nikolaou, Chara Spiliopoulou & Sotiris Athanaselis. (2015) AH-7921: the list of new psychoactive opioids is expanded. Forensic Toxicology 33:2, pages 195-201.
Crossref
Crossref
Pirkko Kriikku, Janne Rintatalo, Katja Pihlainen, Jukka Hurme & Ilkka Ojanperä. (2015) The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland. International Journal of Legal Medicine 129:4, pages 741-749.
Crossref
Crossref
Gavin McLaughlin, Noreen Morris, Pierce V. Kavanagh, John D. Power, Brendan Twamley, John O'Brien, Brian Talbot, Geraldine Dowling, Olivia Mahony, Simon D. Brandt, Julian Patrick, Roland P. Archer, John S. Partilla & Michael H. Baumann. (2015) Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3′,4′-methylenedioxy-4-methylaminorex (MDMAR). Drug Testing and Analysis 7:7, pages 555-564.
Crossref
Crossref
Amira Guirguis, John M. Corkery, Jacqueline L. Stair, Stewart Kirton, Mire Zloh, Christine M. Goodair, Fabrizio Schifano & Colin Davidson. (2015) Survey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacists. Drugs and Alcohol Today 15:2, pages 93-99.
Crossref
Crossref
Marie Bretaudeau Deguigne, S?verine F?rec, B?n?dicte Leli?vre, Chlo? Bruneau, Bertrand Diquet, Patrick Harry & Alain Turcant. (2015) Report of five cases of 2,5-dimethoxy-4-(n)-propylphenethylamine (2C-P) intoxication following recreational use. Toxicologie Analytique et Clinique 27:2, pages 99-104.
Crossref
Crossref
Ayrn D. O?Connor, Angie Padilla-Jones, Richard D. Gerkin & Michael Levine. (2014) Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity: a Comparison of Stimulants. Journal of Medical Toxicology 11:2, pages 195-200.
Crossref
Crossref
Lars Ambach, Ana Hernández Redondo, Stefan König, Verena Angerer, Stefan Schürch & Wolfgang Weinmann. (2015) Detection and quantification of 56 new psychoactive substances in whole blood and urine by LC–MS/MS. Bioanalysis 7:9, pages 1119-1136.
Crossref
Crossref
Veronika Werner, Mario Ellwart, Andreas J. Wagner & Paul Knochel. (2015) Preparation of Tertiary Amines by the Reaction of Iminium Ions Derived from Unsymmetrical Aminals with Zinc and Magnesium Organometallics. Organic Letters 17:8, pages 2026-2029.
Crossref
Crossref
John H. Anneken, Mariana Angoa-Pérez & Donald M. Kuhn. (2015) 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter. Journal of Neurochemistry 133:2, pages 211-222.
Crossref
Crossref
Jennifer E. Naylor, Kevin B. Freeman, Bruce E. Blough, William L. Woolverton & Sally L. Huskinson. (2015) Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained rats. Drug and Alcohol Dependence 149, pages 280-284.
Crossref
Crossref
François Chavant, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul & Danièle Debruyne. (2015) New Synthetic Drugs in Addictovigilance. Therapies 70:2, pages 179-189.
Crossref
Crossref
François Chavant, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul & Danièle Debruyne. (2015) Nouvelles drogues de synthèse en addictovigilance. Therapies 70:2, pages 167-178.
Crossref
Crossref
Mehdi Moini & Christopher M. Rollman. (2015) Compatibility of highly sulfated cyclodextrin with electrospray ionization at low nanoliter/minute flow rates and its application to capillary electrophoresis/electrospray ionization mass spectrometric analysis of cathinone derivatives and their optical i. Rapid Communications in Mass Spectrometry 29:3, pages 304-310.
Crossref
Crossref
Xi-Ling Jiang, Hong-Wu Shen & Ai-Ming Yu. (2015) Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors. Neuropharmacology 89, pages 342-351.
Crossref
Crossref
Elena Durán, Marta Mosquera, Cristina Ruiz, Fernando Bandrés, Francesc Campos, Bartomeu Castanyer, Carme Farré, Juan Fernando Izquierdo, Elena Llorente, Jordi To-Figueras, Salvador Ventura & Josep M. Queraltó. (2015) Desoxipipradrol. Fármacos antiguos, problemas nuevos. Revista del Laboratorio Clínico 8:1, pages 29-38.
Crossref
Crossref
Jane Buckle. 2015. Clinical Aromatherapy. Clinical Aromatherapy
182
194
.
Rohin Francis & Azad Ghuran. 2015. Heart and Toxins. Heart and Toxins
459
491
.
Carina S. D. Wink, Markus R. Meyer, Tina Braun, Alain Turcant & Hans H. Maurer. (2014) Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS n , and LC-high-resolution-MS n. Analytical and Bioanalytical Chemistry 407:3, pages 831-843.
Crossref
Crossref
Magi Farré, Liliana Galindo & Marta Torrens. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives
567
596
.
Simona Pichini, Maria Concetta Rotolo, Jordi García, Noelia Girona, Lorna Leal, Oscar García-Algar & Roberta Pacifici. (2014) Neonatal withdrawal syndrome after chronic maternal consumption of 4-methylethcathinone. Forensic Science International 245, pages e33-e35.
Crossref
Crossref
Piotr Adamowicz, Dariusz Zuba & Bogumiła Byrska. (2014) Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB). Forensic Science International 245, pages 126-132.
Crossref
Crossref
Louise Karlsson, Mikael Andersson, Robert Kronstrand & Fredrik C. Kugelberg. (2014) Mephedrone, Methylone and 3,4-Methylenedioxypyrovalerone (MDPV) Induce Conditioned Place Preference in Mice. Basic & Clinical Pharmacology & Toxicology 115:5, pages 411-416.
Crossref
Crossref
Simona Pichini, Emilia Marchei, Oscar García-Algar, Arelis Gomez, Rita Di Giovannandrea & Roberta Pacifici. (2014) Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers. Journal of Pharmaceutical and Biomedical Analysis 100, pages 284-289.
Crossref
Crossref
Gustavo Merola, Hanzhuo Fu, Franco Tagliaro, Teodora Macchia & Bruce R. McCord. (2014) Chiral separation of 12 cathinone analogs by cyclodextrin-assisted capillary electrophoresis with UV and mass spectrometry detection. ELECTROPHORESIS 35:21-22, pages 3231-3241.
Crossref
Crossref
Ewelina Sieradzka, Katarzyna Witt & Halina Milnerowicz. (2014) The application of capillary electrophoresis techniques in toxicological analysis. Biomedical Chromatography 28:11, pages 1507-1513.
Crossref
Crossref
Julia Dinger, Markus R. Meyer & Hans H. Maurer. (2014) Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse. Toxicology Letters 230:1, pages 28-35.
Crossref
Crossref
Simon Elliott & Julie Evans. (2014) A 3-year review of new psychoactive substances in casework. Forensic Science International 243, pages 55-60.
Crossref
Crossref
Anders Helander, Matilda Bäckberg, Peter Hultén, Yasir Al-Saffar & Olof Beck. (2014) Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project. Forensic Science International 243, pages 23-29.
Crossref
Crossref
Daniel P. Katz, Dwipayan Bhattacharya, Subhrajit Bhattacharya, Jack Deruiter, C. Randall Clark, Vishnu Suppiramaniam & Muralikrishnan Dhanasekaran. (2014) Synthetic cathinones: “A khat and mouse game”. Toxicology Letters 229:2, pages 349-356.
Crossref
Crossref
Michael Singleton, John M. Stogner & Bryan Lee Miller. (2013) Awareness of Novel Drug Legality in a Young Adult Population. American Journal of Criminal Justice 39:3, pages 425-435.
Crossref
Crossref
Kayla N. Ellefsen, Sébastien Anizan, Marisol S. Castaneto, Nathalie A. Desrosiers, Thomas M. Martin, Kevin L. Klette & Marilyn A. Huestis. (2014) Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology. Drug Testing and Analysis 6:7-8, pages 728-738.
Crossref
Crossref
Yan Ni Annie Soh & Simon Elliott. (2014) An investigation of the stability of emerging new psychoactive substances. Drug Testing and Analysis 6:7-8, pages 696-704.
Crossref
Crossref
Richard E. O'Connor & John J. Keating. (2014) Characterization of synthetic routes to ?Bromo-DragonFLY? and benzodifuranyl isopropylamine homologues utilizing ketone intermediates. Part 1: Synthesis of ketone precursors. Drug Testing and Analysis 6:7-8, pages 658-667.
Crossref
Crossref
John C. M. Brust. (2014) Neurologic Complications of Illicit Drug Abuse. CONTINUUM: Lifelong Learning in Neurology 20, pages 642-656.
Crossref
Crossref
Lars Ambach, Ana Hernández Redondo, Stefan König & Wolfgang Weinmann. (2014) Rapid and simple LC-MS/MS screening of 64 novel psychoactive substances using dried blood spots. Drug Testing and Analysis 6:4, pages 367-375.
Crossref
Crossref
Ashton D Lesiak & Jason RE Shepard. (2014) Recent advances in forensic drug analysis by DART-MS. Bioanalysis 6:6, pages 819-842.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging drugs of abuse. Disease-a-Month 60:3, pages 110-132.
Crossref
Crossref
Linda D. Simmler, Anna Rickli, York Schramm, Marius C. Hoener & Matthias E. Liechti. (2014) Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives. Biochemical Pharmacology 88:2, pages 237-244.
Crossref
Crossref
Nicolas Hohmann, Gerd Mikus & David Czock. (2014) Effects and Risks Associated with Novel Psychoactive Substances. Deutsches Ärzteblatt international.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging Drugs of Abuse. Emergency Medicine Clinics of North America 32:1, pages 1-28.
Crossref
Crossref
M. E. Sutter, J. Chenoweth & T. E. Albertson. (2013) Alternative Drugs of Abuse. Clinical Reviews in Allergy & Immunology 46:1, pages 3-18.
Crossref
Crossref
Adam R Winstock, Stephen Kaar & Rohan Borschmann. (2013) Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample. Journal of Psychopharmacology 28:1, pages 49-54.
Crossref
Crossref
Sarah Kerrigan, Ashley Mott, Breanna Jatzlau, Francisco Ortiz, Laura Perrella, Sarah Martin & Kelsie Bryand. (2014) Designer Psychostimulants in Urine by Liquid Chromatography-Tandem Mass Spectrometry,. Journal of Forensic Sciences 59:1, pages 175-183.
Crossref
Crossref
Maria João Valente, Paula Guedes de Pinho, Maria de Lourdes Bastos, Félix Carvalho & Márcia Carvalho. (2013) Khat and synthetic cathinones: a review. Archives of Toxicology 88:1, pages 15-45.
Crossref
Crossref
Janice E. Sullivan & Mark J. McDonald. 2014. Pediatric Critical Care Medicine. Pediatric Critical Care Medicine
695
727
.
Akira Namera, Kyohei Konuma, Takeshi Saito, Shigenori Ota, Hiroshi Oikawa, Shota Miyazaki, Shumari Urabe, Hiroaki Shiraishi & Masataka Nagao. (2013) Simple segmental hair analysis for α-pyrrolidinophenone-type designer drugs by MonoSpin extraction for evaluation of abuse history. Journal of Chromatography B 942-943, pages 15-20.
Crossref
Crossref
Kathryn A. Seely, Amy L. Patton, Cindy L. Moran, Mary L. Womack, Paul L. Prather, William E. Fantegrossi, Anna Radominska-Pandya, Gregory W. Endres, Kermit B. Channell, Nathaniel H. Smith, Keith R. McCain, Laura P. James & Jeffery H. Moran. (2013) Forensic investigation of K2, Spice, and ?bath salt? commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds. Forensic Science International 233:1-3, pages 416-422.
Crossref
Crossref
Alban Cadu, Puspesh K. Upadhyay & Pher G. Andersson. (2013) Iridium‐Catalyzed Asymmetric Hydrogenation of Substituted Pyridines. Asian Journal of Organic Chemistry 2:12, pages 1061-1065.
Crossref
Crossref
Kilak Kesha, Cassie L. Boggs, Mary G. Ripple, Carol H. Allan, Barry Levine, Rebecca Jufer-Phipps, Suzanne Doyon, PaoLin Chi & David R. Fowler. (2013) Methylenedioxypyrovalerone (“Bath Salts”),Related Death: Case Report and Review of the Literature,. Journal of Forensic Sciences 58:6, pages 1654-1659.
Crossref
Crossref
Marie Claire Van Hout & Tim Bingham. (2013) ‘Silk Road’, the virtual drug marketplace: A single case study of user experiences. International Journal of Drug Policy 24:5, pages 385-391.
Crossref
Crossref
Karen Miotto, Joan Striebel, Arthur K. Cho & Christine Wang. (2013) Clinical and pharmacological aspects of bath salt use: A review of the literature and case reports. Drug and Alcohol Dependence 132:1-2, pages 1-12.
Crossref
Crossref
Munidasa Winslow, John CM Wong & Rathi Mahendran. (2013) Plant Food and Incense: The New Substances of Abuse. Annals of the Academy of Medicine, Singapore 42:7, pages 356-357.
Crossref
Crossref
Jeshoor Jebadurai, Fabrizio Schifano & Paolo Deluca. (2013) Recreational use of 1‐(2‐naphthyl)‐2‐(1‐pyrrolidinyl)‐1‐pentanone hydrochloride (NRG‐1), 6‐(2‐aminopropyl) benzofuran (Benzofury/ 6‐APB) and NRG‐2 with review of available evidence‐based literature. Human Psychopharmacology: Clinical and Experimental 28:4, pages 356-364.
Crossref
Crossref
Márcia Sá Monteiro, Maria de Lourdes Bastos, Paula Guedes de Pinho & Márcia Carvalho. (2013) Update on 1-benzylpiperazine (BZP) party pills. Archives of Toxicology 87:6, pages 929-947.
Crossref
Crossref
Xi-Ling Jiang, Hong-Wu Shen, Donald E. Mager & Ai-Ming Yu. (2013)
Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-
N,N
-Dimethyltryptamine, and the Impact of CYP2D6 Status
. Drug Metabolism and Disposition 41:5, pages 975-986.
Crossref
Crossref
Erik W. Gunderson, Matthew G. Kirkpatrick, Laura M. Willing & Christopher P. Holstege. (2013) Substituted Cathinone Products. Journal of Addiction Medicine 7:3, pages 153-162.
Crossref
Crossref
Michael H Baumann, John S Partilla, Kurt R Lehner, Eric B Thorndike, Alexander F Hoffman, Marion Holy, Richard B Rothman, Steven R Goldberg, Carl R Lupica, Harald H Sitte, Simon D Brandt, Srihari R Tella, Nicholas V Cozzi & Charles W Schindler. (2012) Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive ‘Bath Salts’ Products. Neuropsychopharmacology 38:4, pages 552-562.
Crossref
Crossref
Pirkko Kriikku, Lars Wilhelm, Janne Rintatalo, Jukka Hurme, Jan Kramer & Ilkka Ojanperä. (2013) Prevalence and blood concentrations of desoxypipradrol (2-DPMP) in drivers suspected of driving under the influence of drugs and in post-mortem cases. Forensic Science International 226:1-3, pages 146-151.
Crossref
Crossref
Madeleine J. Swortwood, Diane M. Boland & Anthony P. DeCaprio. (2012) Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis. Analytical and Bioanalytical Chemistry 405:4, pages 1383-1397.
Crossref
Crossref
Alan L Hudson, Maggie D Lalies, Glen B Baker, Kristopher Wells & Katherine J Aitchison. (2014) Ecstasy, legal highs and designer drug use: A Canadian perspective. Drug Science, Policy and Law 1, pages 205032451350919.
Crossref
Crossref
G. T. C. Wong & M. G. Irwin. (2013) Poisoning with illicit substances: toxicology for the anaesthetist. Anaesthesia 68, pages 117-124.
Crossref
Crossref
Bénédicte Lelièvre, Séverine Férec, David Boels, Mohammed Bennaceur, Patrick Harry, Chadi Abbara, Bertrand Diquet & Alain Turcant. (2013) Le désoxypipradrol, une nouvelle drogue disponible sur Internet : à propos d’un cas. Annales de Toxicologie Analytique 25:2, pages 57-62.
Crossref
Crossref
Alban Cadu & Pher G. Andersson. (2013) Iridium catalysis: application of asymmetric reductive hydrogenation. Dalton Transactions 42:40, pages 14345.
Crossref
Crossref
Displaying 200 of 213 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list